Brilliant Violet 605™ anti-mouse CD45.2 Antibody

Pricing & Availability
Clone
104 (See other available formats)
Regulatory Status
RUO
Other Names
Ly-5.2, LCA
Isotype
Mouse (SJL) IgG2a, κ
104_BV605_CD45.2_Antibody_FC_042414.jpg
C57BL/6 mouse splenocytes were stained with CD45.2 (clone 104) Brilliant Violet 605™ (filled histogram) or mouse IgG2a, κ Brilliant Violet 605™ isotype control (open histogram).
  • 104_BV605_CD45.2_Antibody_FC_042414.jpg
    C57BL/6 mouse splenocytes were stained with CD45.2 (clone 104) Brilliant Violet 605™ (filled histogram) or mouse IgG2a, κ Brilliant Violet 605™ isotype control (open histogram).
Compare all formats See Brilliant Violet 605™ spectral data
Cat # Size Price Quantity Check Availability
109841 50 µg $262.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45.2 is an alloantigen of CD45, expressed by Ly5.2 bearing mouse strains (e.g., A, AKR, BALB/c, CBA/Ca, CBA/J, C3H/He, C57BL, C57BR, C57L, C58, DBA/1, DBA/2, NZB, SWR, 129). CD45, a member of the protein tyrosine phosphatase (PTP) family, is a 180-240 kD glycoprotein expressed on all hematopoietic cells except mature erythrocytes and platelets. There are multiple isoforms in the mouse that play key roles in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation states of the cell as well as specific cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
B10.S mouse thymocytes and splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
Preparation
The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 605™ under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.5 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Brilliant Violet 605™ excites at 405 nm and emits at 603 nm. The bandpass filter 610/20 nm is recommended for detection, although filter optimization may be required depending on other fluorophores used. Be sure to verify that your cytometer configuration and software setup are appropriate for detecting this channel. Refer to your instrument manual or manufacturer for support. Brilliant Violet 605™ is a trademark of Sirigen Group Ltd.


Learn more about Brilliant Violet™.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.
Excitation Laser
Violet Laser (405 nm)
Application Notes

The 104 antibody does not react with mouse cells expressing the CD45.1 alloantigen. Additional reported applications (for the relevant formats) include: immunoprecipitation4, in vivo and in vitro blocking of B cell responses1,2, and immunohistochemical staining of acetone-fixed frozen sections3. 

Application References

(PubMed link indicates BioLegend citation)
  1. Yakura H, et al. 1983. J. Exp. Med. 157:1077. (Block)
  2. Yakura H, et al. 1986. J. Immunol. 136:2729. (Block)
  3. Suzuki K, et al. 2000. Immunity 13:691. (IHC)
  4. Shen FW, et al. 1986. Immunogenetics 24:146. (IP)
  5. Baldwin TA and Hogquist KA. 2007. J. Immunol. 179:837.
  6. Pascal V, et al. 2007. J. Immunol. 179:1751.
  7. Burman AC, et al. 2007. Blood 110:1064.
  8. Kincaid EZ, et al. 2007. J. Immunol. 179:3187.
  9. Phan TG, et al. 2007. Nature Immunol. 8:992.
  10. Nakano-Yokomizo T, et al. 2011. J. Exp Med. 208:1661. PubMed
  11. Wen T, et al. 2013. PNAS. 110:6067. PubMed
  12. Kohlmeier JE, et al. 2008. Immunity. 29:101. (FC) PubMed
Product Citations
  1. Hirai T, et al. 2020. Immunity. 54(1):84-98.e5. PubMed
  2. Vasanthakumar A, et al. 2020. Nature. 579:581. PubMed
  3. Chaurio RA, et al. 2022. Immunity. 55:115. PubMed
  4. Hu Q, et al. 2022. Cell Rep. 40:111035. PubMed
  5. Marié IJ, et al. 2022. Bio Protoc. 12:e4438. PubMed
  6. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  7. Bohrer AC, et al. 2022. Cell Rep. 40:111144. PubMed
  8. Le DT, et al. 2023. iScience. 26:106059. PubMed
  9. Yazicioglu YF, et al. 2023. Nat Immunol. 24:991. PubMed
  10. Lütge M, et al. 2023. Nat Immunol. . PubMed
  11. Park S, et al. 2021. Front Immunol. 11:620166. PubMed
  12. Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
  13. Lee JL, et al. 2022. Aging Cell. 21:e13692. PubMed
  14. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  15. Sharma S, et al. 2015. J Immunol. 194:5529. PubMed
  16. Yoshimi A, et al. 2019. Nature. 574:273. PubMed
  17. Perry JSA, et al. 2018. Immunity. 48:923. PubMed
  18. Pauken KE, et al. 2020. Cell Reports. 31(13):107827. PubMed
  19. Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed
  20. Duan L, et al. 2021. Immunity. 54:2256. PubMed
  21. Watanabe K, et al. 2018. JCI Insight. 3. PubMed
  22. Mintz MA, et al. 2019. Immunity. 51:310. PubMed
  23. Deng M, et al. 2020. Nat Commun. 11:2193. PubMed
  24. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  25. Gañán-Gómez I, et al. 2022. Nat Med. . PubMed
  26. Camell CD, et al. 2020. Cell Metabolism. 30(6):1024-1039.e6.. PubMed
  27. Shi L, et al. 2016. Nat Commun. 7:12335. PubMed
  28. Faust HJ, et al. 2020. J Clin Invest. 130:5493. PubMed
  29. Shen JZ, et al. 2020. Cell. 184(2):352-369.e23. PubMed
  30. Jin C, et al. 2019. Cell. 176:998. PubMed
  31. Toshiro Hirai et al. 2019. Immunity. 50(5):1249-1261 . PubMed
  32. Guccini I, et al. 2020. Cancer Cell. 39(1):68-82.e9. PubMed
  33. Giampazolias E, et al. 2021. Cell. . PubMed
  34. Florez MA, et al. 2020. Cell Rep. 33:108530. PubMed
  35. Hormaechea-Agulla D, et al. 2021. Cell Stem Cell. . PubMed
  36. Nelson CE et al. 2019. Cell Rep. 28(12):3092-3104 . PubMed
  37. Zhang Y, et al. 2019. Nat Commun. 10:3667. PubMed
  38. Lee SC et al. 2018. Cancer cell. 34(2):225-241 . PubMed
  39. Celik H, et al. 2018. Cancer Cell. 34:741. PubMed
  40. Hu J, et al. 2022. J Immunother Cancer. 10:. PubMed
  41. Kim MY, et al. 2022. Nat Commun. 13:3296. PubMed
  42. Hodgson R, et al. 2022. Commun Biol. 5:1216. PubMed
RRID
AB_2563485 (BioLegend Cat. No. 109841)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets of the CD45.2 strain of mice

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules
Antigen References

1. Suzuki K, et al. 2000. Immunity 13:691.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45.2 on UniProt.org

Other Formats

View All CD45.2 Reagents Request Custom Conjugation
Description Clone Applications
Biotin anti-mouse CD45.2 104 FC
FITC anti-mouse CD45.2 104 FC
PE anti-mouse CD45.2 104 FC
Purified anti-mouse CD45.2 104 FC,Block,IHC-F,IP
APC anti-mouse CD45.2 104 FC
Alexa Fluor® 488 anti-mouse CD45.2 104 FC
Alexa Fluor® 647 anti-mouse CD45.2 104 FC
Pacific Blue™ anti-mouse CD45.2 104 FC
Alexa Fluor® 700 anti-mouse CD45.2 104 FC
APC/Cyanine7 anti-mouse CD45.2 104 FC
PerCP anti-mouse CD45.2 104 FC
PerCP/Cyanine5.5 anti-mouse CD45.2 104 FC
PE/Cyanine7 anti-mouse CD45.2 104 FC
Brilliant Violet 421™ anti-mouse CD45.2 104 FC
Brilliant Violet 570™ anti-mouse CD45.2 104 FC
Brilliant Violet 650™ anti-mouse CD45.2 104 FC
Brilliant Violet 510™ anti-mouse CD45.2 104 FC
Brilliant Violet 785™ anti-mouse CD45.2 104 FC
Brilliant Violet 605™ anti-mouse CD45.2 104 FC
Purified anti-mouse CD45.2 (Maxpar® Ready) 104 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse CD45.2 104 FC
Brilliant Violet 711™ anti-mouse CD45.2 104 FC
Alexa Fluor® 594 anti-mouse CD45.2 104 IHC-F,SB
APC/Fire™ 750 anti-mouse CD45.2 104 FC
TotalSeq™-A0157 anti-mouse CD45.2 104 PG
TotalSeq™-B0157 anti-mouse CD45.2 104 PG
TotalSeq™-C0157 anti-mouse CD45.2 104 PG
Brilliant Violet 750™ anti-mouse CD45.2 104 FC
Spark Blue™ 550 anti-mouse CD45.2 104 FC
Spark NIR™ 685 anti-mouse CD45.2 104 FC
Spark UV™ 387 anti-mouse CD45.2 104 FC
Spark Blue™ 574 anti-mouse CD45.2 (Flexi-Fluor™) 104 FC
Spark Red™ 718 anti-mouse CD45.2 (Flexi-Fluor™) 104 FC
Go To Top Version: 1    Revision Date: 04/29/2014

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Login/Register
Forgot your password? Reset Password
Request an Account